Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity
Authors
Keywords
-
Journal
CLINICAL NUTRITION
Volume 41, Issue 9, Pages 1969-1976
Publisher
Elsevier BV
Online
2022-07-19
DOI
10.1016/j.clnu.2022.07.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial
- (2022) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study
- (2021) Nikolaos Perakakis et al. DIABETES OBESITY & METABOLISM
- Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis
- (2021) Nikolaos Perakakis et al. LIVER INTERNATIONAL
- The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective
- (2021) J. Michael Conlon Frontiers in Endocrinology
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of glicentin and oxyntomodulin in human metabolism: new evidence and new directions
- (2020) Nikolaos Perakakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acute Effects of Three Different Meal Patterns on Postprandial Metabolism in Older Individuals with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Controlled Crossover Trial
- (2020) Yannik B. Schönknecht et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Effect of the glucagon‐like peptide‐1 analogue liraglutide versus placebo treatment on circulating proglucagon‐derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial
- (2020) Sun H. Kim et al. DIABETES OBESITY & METABOLISM
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
- (2019) Preeshila Behary et al. DIABETES CARE
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Methods and Guidelines for Measurement of Glucagon in Plasma
- (2019) Jens J. Holst et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD
- (2019) Stergios A Polyzos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
- (2019) Alexander Kokkinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity
- (2019) Victoria Higgins et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Reduced GLP-1 Secretion at 30 Minutes After a 75g Oral Glucose Load is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study
- (2018) Nithya Sukumar et al. DIABETES
- Follistatins in glucose regulation in healthy and obese individuals
- (2018) Nikolaos Perakakis et al. DIABETES OBESITY & METABOLISM
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon action in the brain
- (2016) Mona A. Abraham et al. DIABETOLOGIA
- Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis
- (2016) Maria T. Vamvini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
- (2016) Hannes Manell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma
- (2016) Nicolai J. Wewer Albrechtsen et al. EBioMedicine
- Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
- (2016) Niina Matikainen et al. PLoS One
- GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
- (2015) Kristine Færch et al. DIABETES
- Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure
- (2015) Jonatan Ising Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance
- (2013) Niina Matikainen et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
- (2013) S. Calanna et al. DIABETOLOGIA
- Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial
- (2013) Anna Gavrieli et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals
- (2013) A. Gavrieli et al. Obesity
- Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans
- (2011) Ola Lindgren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
- (2011) Jonatan I. Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rise of Oxyntomodulin in Response to Oral Glucose after Gastric Bypass Surgery in Patients with Type 2 Diabetes
- (2010) Blandine Laferrère et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incretin and islet hormonal responses to fat and protein ingestion in healthy men
- (2008) Richard D. Carr et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started